BHI News Section Archives - Page 62 of 1201

News

January 16, 2024

Rockville’s NeoImmuneTech Welcomes a New President for its Development and Business

ROCKVILLE, Md., Jan. 15, 2024 /PRNewswire/ -- NeoImmuneTech, Inc. (NIT or "NeoImmuneTech"), a clinical-stage T cell-focused biopharmaceutical company, today announces the appointment…

Andy

Love0

News

January 15, 2024

Bio.News: With the new COVID surge, are we really post-pandemic?

January 9, 2024 / By Clary Estes - National wastewater viral activity levels for COVID-19 have been  very high since December. (It wasn’t your imagination that…

Andy

Love0

News

January 11, 2024

Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense

GAITHERSBURG, Md., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has secured an indefinite-delivery, indefinite-quantity (IDIQ) procurement contract…

Andy

Love0

News

January 10, 2024

GSK Enters Agreement to Acquire Aiolos Bio

Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway AIO-001 could…

Andy

Love0

News

January 9, 2024

KeifeRx Expands Exclusive Licensing Agreement with Georgetown University to Include Multiple Disease Indications for Portfolio of Novel Tyrosine Kinase Inhibitors

KeifeRx is currently advancing programs investigating KFRX03, KFRX04, KFXR05 and KFX06 in neurodegenerative, neuroinflammatory, and mast cell-associated diseases WASHINGTON, Jan. 8,…

Andy

Love0

News

January 9, 2024

Rockville’s Shuttle Pharmaceuticals Receives FDA Approval to Proceed with Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

ROCKVILLE, Md., Jan. 8, 2024 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma") today announced they have received the 'Safe to…

Andy

Love0

News

January 9, 2024

Creation of the Emmes Group Will Advance Company’s 47-year Legacy and Build Clinical Research Infrastructure for the Future

New Business Unit Veridix AI Launched to Embed Technology and AI in Day-to-Day Clinical Operations Dr. Rama Kondru to Join…

Andy

Love0

News

January 8, 2024

Research and development (R&D) that will contribute toward Advanced Research Projects Agency for Health (ARPA-H) mission needs and Small Business Innovation Research (SBIR) program objectives.

The Advanced Research Projects Agency for Health (ARPA-H) is soliciting proposals from small business concerns that possess the research and…

Andy

Love0

News

January 8, 2024

Nanochon’s Orthopedic Revolution: A New Era in Cartilage Restoration on BioTalk

Are you prepared to discover a transformative shift in orthopedic innovation? Join us in this episode of BioTalk with Rich…

Andy

Love0

BioTalk with Rich Bendis Podcast

January 8, 2024

Nanochon’s Orthopedic Revolution: A New Era in Cartilage Restoration on BioTalk

Are you prepared to discover a transformative shift in orthopedic innovation? Join us in this episode of BioTalk with Rich…

Andy

Love0

BHI News Section

Rockville’s NeoImmuneTech Welcomes a New President for its Development and Business

Bio.News: With the new COVID surge, are we really post-pandemic?

Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense

GSK Enters Agreement to Acquire Aiolos Bio

KeifeRx Expands Exclusive Licensing Agreement with Georgetown University to Include Multiple Disease Indications for Portfolio of Novel Tyrosine Kinase Inhibitors

Rockville’s Shuttle Pharmaceuticals Receives FDA Approval to Proceed with Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

Creation of the Emmes Group Will Advance Company’s 47-year Legacy and Build Clinical Research Infrastructure for the Future

Research and development (R&D) that will contribute toward Advanced Research Projects Agency for Health (ARPA-H) mission needs and Small Business Innovation Research (SBIR) program objectives.

Nanochon’s Orthopedic Revolution: A New Era in Cartilage Restoration on BioTalk

Nanochon’s Orthopedic Revolution: A New Era in Cartilage Restoration on BioTalk

About BioHealth Innovation

Contact

Connect

BHI News Section

About BioHealth Innovation

Contact

Connect

Search